<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
OCGN
Ocugen
$
()


  • Ocugen price target raised by $1 at Chardan, here's why

    4/22/2024 - 07:44am
  • Ocugen announces dosing completion of Cohort 2 in OCU410 Phase 1/2 trial

    4/19/2024 - 07:14am
  • Ocugen files $175M mixed securities shelf

    4/18/2024 - 06:03am
  • What You Missed On Wall Street On Wednesday

    4/10/2024 - 16:25pm
  • What You Missed On Wall Street This Morning

    4/10/2024 - 12:00pm
  • Ocugen announces CHMP of EMA reviewed Phase 3 study design for OCU400

    4/10/2024 - 07:10am
  • Ocugen: FDA clears IND amendment to initiate Phase 3 clinical trial of OCU400

    4/8/2024 - 06:39am
  • What You Missed On Wall Street On Friday

    4/5/2024 - 16:08pm
  • What You Missed On Wall Street This Morning

    4/5/2024 - 12:03pm
  • Ocugen says DSMB approves medium dose cohort dosing in OCU410 study

    4/5/2024 - 07:04am
  • Ocugen provides business update

    4/2/2024 - 08:24am
  • Ocugen announces positive DSMB review of OCU410ST trial

    4/1/2024 - 18:11pm
  • What You Missed On Wall Street On Monday

    3/18/2024 - 16:23pm
  • What You Missed On Wall Street This Morning

    3/18/2024 - 12:05pm
  • Ocugen names Huma Qamar, MD, MPH as Chief Medical Officer

    3/18/2024 - 06:35am
dynamic_feed Breaking News